|
1
|
Toker C: Trabecular carcinoma of the skin.
Arch Dermatol. 105:107–110. 1972. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Paulson KG, Park SY, Vandeven NA, Lachance
K, Thomas H, Chapuis AG, Harms KL, Thompson JA, Bhatia S, Stang A
and Nghiem P: Merkel cell carcinoma: Current US incidence and
projected increases based on changing demographics. J Am Acad
Dermatol. 78:457–463.e2. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zaar O, Gillstedt M, Lindelöf B,
Wennberg-Larkö AM and Paoli J: Merkel cell carcinoma incidence is
increasing in Sweden. J Eur Acad Dermatol Venereol. 30:1708–1713.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fondain M, Dereure O, Uhry Z, Guizard AV,
Woronoff AS, Colonna M, Molinie F, Bara S, Velten M, Marrer E, et
al: Merkel cell carcinoma in France: A registries-based,
comprehensive epidemiological survey. J Eur Acad Dermatol Venereol.
32:1292–1296. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Coggshall K, Tello TL, North JP and Yu SS:
Merkel cell carcinoma: An update and review: Pathogenesis,
diagnosis, and staging. J Am Acad Dermatol. 78:433–442. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fazio N, Maisonneuve P, Spada F, Gervaso
L, Cella CA, Pozzari M, Zerini D, Pisa E, Fumagalli C, Barberis M,
et al: Nodal merkel cell carcinoma with unknown primary site and no
distant metastasis: A single-center series. Cancers (Basel).
14:47772022. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Feng H, Shuda M, Chang Y and Moore PS:
Clonal integration of a polyomavirus in human Merkel cell
carcinoma. Science. 319:1096–1100. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Moll I, Zieger W and Schmelz M:
Proliferative Merkel cells were not detected in human skin. Arch
Dermatol Res. 288:184–187. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zur Hausen A, Rennspiess D, Winnepenninckx
V, Speel EJ and Kurz AK: Early B-cell differentiation in Merkel
cell carcinomas: Clues to cellular ancestry. Cancer Res.
73:4982–4987. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zaggana E, Konstantinou MP, Krasagakis GH,
de Bree E, Kalpakis K, Mavroudis D and Krasagakis K: Merkel cell
carcinoma-update on diagnosis, management and future perspectives.
Cancers (Basel). 15:1032022. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tello TL, Coggshall K, Yom SS and Yu SS:
Merkel cell carcinoma: An update and review: Current and future
therapy. J Am Acad Dermatol. 78:445–454. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen L, Zhu L, Wu J, Lin T, Sun B and He
Y: Giant Merkel cell carcinoma of the eyelid: A case report and
review of the literature. World J Surg Oncol. 9:582011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Watanabe N, Shimizu M, Kageyama M,
Kitagawa K, Hayasaka S and Seto H: 123I-MIBG SPECT of Merkel cell
carcinoma. Br J Radiol. 71:886–887. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Feng Y, Song X and Jia R: Case Report:
Favorable response to the tyrosine kinase inhibitor apatinib in
recurrent merkel cell carcinoma. Front Oncol. 11:6253602021.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dunlop P, Sapp H, Logan PM and Walsh NM:
Merkel cell carcinoma of the abdominal wall. Skeletal Radiol.
27:396–399. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Moayed S, Maldjianb C, Adam R and
Bonakdarpour A: Magnetic resonance imaging appearance of metastatic
Merkel cell carcinoma to the sacrum and epidural space. Magn Reson
Imaging. 18:1039–1042. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hawryluk EB, O'Regan KN, Sheehy N, Guo Y,
Dorosario A, Sakellis CG, Jacene HA and Wang LC: Positron emission
tomography/computed tomography imaging in Merkel cell carcinoma: A
study of 270 scans in 97 patients at the Dana-Farber/Brigham and
Women's Cancer Center. J Am Acad Dermatol. 68:592–599. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Concannon R, Larcos GS and Veness M: The
impact of (18)F-FDG PET-CT scanning for staging and management of
Merkel cell carcinoma: Results from Westmead Hospital, Sydney,
Australia. J Am Acad Dermatol. 62:76–84. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Akaike G, Akaike T, Fadl SA, Lachance K,
Nghiem P and Behnia F: Imaging of merkel cell carcinoma: What
imaging experts should know. Radiographics. 39:2069–2084. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Peloschek P, Novotny C, Mueller-Mang C,
Weber M, Sailer J, Dawid M, Czerny C, Dudczak R, Kletter K and
Becherer A: Diagnostic imaging in Merkel cell carcinoma: Lessons to
learn from 16 cases with correlation of sonography, CT, MRI and
PET. Eur J Radiol. 73:317–323. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kim HJ, Lee KC, Kang CH, Ahn KS and Kim
CH: Characteristic imaging features of merkel cell carcinoma: A
case report. Curr Med Imaging. 17:562–566. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Enzenhofer E, Ubl P, Czerny C and Erovic
BM: Imaging in patients with merkel cell carcinoma. J Skin Cancer.
2013:9731232013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shoji MK, Tran AQ, Lazzarini TA, Choi CJ
and Tse BC: Basal cell carcinoma and eccrine porocarcinoma of the
eyelid. Ophthalmic Plast Reconstr Surg. 37:e53–e56. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tang M, Huang R, Chen J, Sheng M, Zhang Z,
Xing J, Guo L and Li Y: Clinical value of high-resolution dynamic
contrast-enhanced (DCE) MRI in diagnosis of cutaneous squamous cell
carcinoma. Skin Res Technol. 27:511–520. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Soror NN, Lutaya I, Shah P, Hemrock L,
Bennett R and Gibson G: A rare case of primary adenocarcinoma of
the eyelid: Case presentation and review of literature. Cureus.
13:e165802021.PubMed/NCBI
|
|
26
|
Barat M, Guegan-Bart S, Cottereau AS,
Guillo E, Hoeffel C, Barret M, Gaujoux S, Dohan A and Soyer P: CT,
MRI and PET/CT features of abdominal manifestations of cutaneous
melanoma: A review of current concepts in the era of tumor-specific
therapies. Abdom Radiol (NY). 46:2219–2235. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Evans J, Vo KBH and Schmitt M: Chalazion:
Racial risk factors for formation, recurrence, and surgical
intervention. Can J Ophthalmol. 57:242–246. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Schrama D, Sarosi EM, Adam C, Ritter C,
Kaemmerer U, Klopocki E, König EM, Utikal J, Becker JC and Houben
R: Characterization of six Merkel cell polyomavirus-positive Merkel
cell carcinoma cell lines: Integration pattern suggest that large T
antigen truncating events occur before or during integration. Int J
Cancer. 145:1020–1032. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kervarrec T, Tallet A,
Miquelestorena-Standley E, Houben R, Schrama D, Gambichler T,
Berthon P, Le Corre Y, Hainaut-Wierzbicka E, Aubin F, et al:
Diagnostic accuracy of a panel of immunohistochemical and molecular
markers to distinguish Merkel cell carcinoma from other
neuroendocrine carcinomas. Mod Pathol. 32:499–510. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bichakjian CK, Olencki T, Aasi SZ, Alam M,
Andersen JS, Blitzblau R, Bowen GM, Contreras CM, Daniels GA,
Decker R, et al: Merkel Cell Carcinoma, Version 1.2018, NCCN
Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw.
16:742–774. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Dasanu CA, Del Rosario M, Codreanu I,
Hyams DM and Plaxe SC: Inferior outcomes in immunocompromised
Merkel cell carcinoma patients: Can they be overcome by the use of
PD1/PDL1 inhibitors. J Oncol Pharm Pract. 25:214–216. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Frohm ML, Griffith KA, Harms KL, Hayman
JA, Fullen DR, Nelson CC, Wong SL, Schwartz JL and Bichakjian CK:
Recurrence and survival in patients with merkel cell carcinoma
undergoing surgery without adjuvant radiation therapy to the
primary site. JAMA Dermatol. 152:1001–1007. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kaufman HL, Russell J, Hamid O, Bhatia S,
Terheyden P, D'Angelo SP, Shih KC, Lebbé C, Linette GP, Milella M,
et al: Avelumab in patients with chemotherapy-refractory metastatic
Merkel cell carcinoma: A multicentre, single-group, open-label,
phase 2 trial. Lancet Oncol. 17:1374–1385. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lemos BD, Storer BE, Iyer JG, Phillips JL,
Bichakjian CK, Fang LC, Johnson TM, Liegeois-Kwon NJ, Otley CC,
Paulson KG, et al: Pathologic nodal evaluation improves prognostic
accuracy in Merkel cell carcinoma: Analysis of 5823 cases as the
basis of the first consensus staging system. J Am Acad Dermatol.
63:751–761. 2010. View Article : Google Scholar : PubMed/NCBI
|
